BCRX insider buying
1 cluster buyBIOCRYST PHARMACEUTICALS INC · Healthcare
When two or more insiders at BIOCRYST PHARMACEUTICALS INC buy BCRX in a qualifying detection window, the grouped purchases provide a starting point for further research. Below is every cluster we've detected in BCRX plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.
Detected clusters
- May 13 – May 14, 2024Detected May 14, 2024Executive buyer5 insidersTotal bought$829.0KMarket cap$2.6B
All notable open-market buys in BCRX
Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| May 30, 2024 | Director | 7,861 | $6.36 | $50.0K | SEC ↗ |
| May 24, 2024 | Director | 2,500 | $6.40 | $16.0K | SEC ↗ |
| May 20, 2024 | Director | 15,000 | $6.25 | $93.8K | SEC ↗ |
| May 20, 2024 | Director | 5,000 | $6.38 | $31.9K | SEC ↗ |
| May 14, 2024 | Doyle Anthonycluster Chief Financial Officer | 36,300 | $5.57 | $202.2K | SEC ↗ |
| May 14, 2024 | Thackray Helen M.cluster Chief R&D Officer | 30,000 | $5.86 | $175.8K | SEC ↗ |
| May 13, 2024 | Stonehouse Jon Pcluster Director, President & CEO | 30,000 | $5.55 | $166.5K | SEC ↗ |
| May 13, 2024 | Gayer Charles Kcluster Chief Commercial Officer | 30,000 | $5.47 | $164.1K | SEC ↗ |
| May 13, 2024 | Galson Steven Kcluster Director | 21,940 | $5.49 | $120.5K | SEC ↗ |
| May 13, 2024 | Chief Legal Officer | 5,000 | $5.53 | $27.7K | SEC ↗ |
More Healthcare stocks with insider cluster buys
BCRX insider buying — FAQ
- Are insiders buying BCRX stock?
- Yes — 10 distinct insiders have bought BCRX (BIOCRYST PHARMACEUTICALS INC) on the open market, including 1 cluster buy where two or more insiders bought within a rolling window. The most recent qualifying activity was May 31, 2024.
- How much BCRX stock have insiders bought?
- Insiders have bought a combined $1.0M of BCRX across 10 open-market purchases, based on SEC Form 4 filings.
- What is an insider cluster buy in BCRX?
- A cluster buy is two or more distinct BIOCRYST PHARMACEUTICALS INC insiders — officers, directors, or 10% owners — each buying BCRX on the open market within a rolling window. BCRX has 1 detected cluster buy to date.
- Where does this BCRX insider trading data come from?
- Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.
How we track insider buying in BCRX
We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy BCRX within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Transactions link to official filings; prices and market capitalizations may be cached market data. Read our methodology and data limits before interpreting the figures. What counts as a cluster buy?
This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding BCRX.